CoChat

Clinical Trials in Youth-Onset Type 2 Diabetes: Needs, Barriers, and Options

Zeitler, Philip, Chou, Hubert S., Copeland, Kenneth C., Geffner, Mitchell · 2015 · Current Diabetes Reports
Cited by 26

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s11892-015-0597-2

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Research works printed but not linked: 16

  1. Cefalu W. TODAY reflects on the changing “faces” of type 2 diabetes. Diabetes Care. 2013;36:1732–4. · DOI
  2. TODAY Study Group, Zeitler P, Hirst K, Pyle L, Linder B, Copeland K, et al. A clinical trial to maintain glycemic control in youth with type 2 diabetes. N Engl J Med. 2012;366:2247–56. This article reports the primary findings of the TODAY study, the first large trial examining the efficacy of medication and lifestyle intervention in youth-onset T2D. · DOI · Paper page
  3. Kahn SE, Haffner SM, Heise MA, et al. Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. N Engl J Med. 2006;355:2427–43. · DOI · Paper page
  4. Brown JB, Conner C, Nichols GA. Secondary failure of metformin monotherapy in clinical practice. Diabetes Care. 2010;33:501–6. · DOI · Paper page
  5. TODAY Study Group. Rapid rise in hypertension and nephropathy in youth with type 2 diabetes: the TODAY clinical trial. Diabetes Care. 2013;36:1735–41. · DOI · Paper page
  6. Gottschalk M, Danne T, Vlajnic A, Cara JF. Glimepiride versus metformin as monotherapy in pediatric patients with type 2 diabetes: a randomized, single-blind comparative study. Diabetes Care. 2007;30:790–4. · DOI · Paper page
  7. Baranowski T, Cooper DM, Harrell J, Hirst K, Kaufman FR, Goran M, et al. Presence of diabetes risk factors in a large U.S. eighth-grade cohort. Diabetes Care. 2006;29:212–7. · DOI · Paper page
  8. Klingensmith GJ, Pyle L, Arslanian S, Copeland KC, Cuttler L, Kaufman F, et al. The presence of GAD and IA-2 antibodies in youth with a type 2 diabetes phenotype: results from the TODAY study. Diabetes Care. 2010;33:1970–5. · DOI · Paper page
  9. Zeitler P, Fu J, Tandon N, Nadeau K, Urakami T, Barrett T, et al. Type 2 diabetes in the child and adolescent. Pediatr Diabetes. 2014;15 Suppl 20:26–46. Guidelines from the International Society for Pediatric and Adolescent Diabetes regarding the diagnosis and management of T2D in adolescents. · DOI · Paper page
  10. Laffel L, Chang N, Grey M, Hale D, Higgins L, Hirst K, et al. Metformin monotherapy in youth with recent onset type 2 diabetes: experience from the prerandomization run-in phase of the TODAY study. Pediatr Diabetes. 2012;13:369–75. · DOI
  11. Hudson OD, Nunez M, Shaibi GQ. Ethnicity and elevated liver transaminases among newly diagnosed children with type 2 diabetes. BMC Pediatr. 2012;12:174. · DOI
  12. Bobo WV, Cooper WO, Stein CM, Olfson M, Graham D, Daugherty J, et al. Antipsychotics and the risk of type 2 diabetes mellitus in children and youth. JAMA Psychiatry. 2013;70:1067–75. · DOI · Paper page
  13. Copeland KC, Zeitler P, Geffner M, Guandalini C, Higgins J, Hirst K, et al. Characteristics of adolescents and youth with recent-onset type 2 diabetes: the TODAY cohort at baseline. J Clin Endocrinol Metab. 2011;96:159–67. This article provides in-depth information regarding the characteristics of the population with youth-onset T2D. · DOI · Paper page
  14. Bacha F, Pyle L, Nadeau K, Cuttler L, Goland R, Haymond M, et al. Determinants of glycemic control in youth with type 2 diabetes at randomization in the TODAY study. Pediatr Diabetes. 2012;13:376–83. · DOI · Paper page
  15. Reinehr T, Kiess W, Kapellen T, Wiegand S, Holl RW, APV and DPV Wiss Study Group and German Competence Net Obesity. Children with diabetes mellitus type 2 in Europe: an underserved population. Arch Dis Child. 2010;95:954. · DOI · Paper page
  16. TODAY Study Group, Wilfley D, Berkowitz R, Goebel-Fabbri A, Hirst K, Ievers-Landis C, et al. Binge eating, mood, and quality of life in youth with type 2 diabetes: baseline data from the TODAY study. Diabetes Care. 2011;34:858–60. · DOI · Paper page

Cited by

See all 26

Metadata

Authors
Zeitler, P., Chou, H. S., Copeland, K. C., & Geffner, M.
Venue
Current Diabetes Reports
Published
2015-03-18
Volume
15
Issue
5
ISSN
  • 1534-4827
  • 1539-0829
Cited by
26
References
6
Language
en
Licence
www.springer.com/tdm (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Clinical Trials in Youth-Onset Type 2 Diabetes: Needs, Barriers, and Options. https://app.cochat.ai/papers/10.1007/s11892-015-0597-2
The paper
Zeitler, P., Chou, H. S., Copeland, K. C., & Geffner, M. (2015). Clinical Trials in Youth-Onset Type 2 Diabetes: Needs, Barriers, and Options. Current Diabetes Reports. https://doi.org/10.1007/s11892-015-0597-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.